{"id":5199,"date":"2023-01-20T15:42:00","date_gmt":"2023-01-20T12:42:00","guid":{"rendered":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2026\/01\/19\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/"},"modified":"2026-01-19T11:11:22","modified_gmt":"2026-01-19T08:11:22","slug":"saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk","status":"publish","type":"post","link":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/","title":{"rendered":"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK."},"content":{"rendered":"<div style=\"padding-bottom: 100px; margin: auto; width: 90%; display: flex; justify-content: center; flex-direction: column;\">\n<p>Bilindi\u011fi \u00fczere 25.08.2022 tarihli ve 31934 say\u0131l\u0131 resm\u00ee gazetede yay\u0131mlanan \u201cSosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde De\u011fi\u015fiklik Yap\u0131lmas\u0131na Dair Tebli\u011f \u201c kapsam\u0131nda Sa\u011fl\u0131k Uygulama Tebli\u011finin 4.2.7 D\u00fc\u015f\u00fck Molek\u00fcl A\u011f\u0131rl\u0131kl\u0131 Heparinlerin Kullan\u0131m ilkelerinde de de\u011fi\u015fikli\u011fe gidilmi\u015ftir. Buna istinaden Oksapar ,Enox vb. Enoksaparin i\u00e7eren m\u00fcstahzarlara ait \u00e7\u0131kar\u0131lacak ilk rapor uzman hekimlerce d\u00fczenlenen 3 ay s\u00fcreli sa\u011fl\u0131k raporudur. Bu ilk rapor 3 ay boyunca \u201c280-ba\u015flang\u0131\u00e7 tedavisi \u201cuyar\u0131 kodu ile i\u015fleme al\u0131nabilir.&nbsp;<\/p>\n<p>&nbsp;Daha sonra devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lmas\u0131 gereken raporlar en fazla 1 y\u0131l s\u00fcreli olup, rapor d\u00fczenlenme t\u00fcr\u00fc 3 hekimli SA\u011eLIK KURULU raporu olmal\u0131d\u0131r. Devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lan bu raporlar\u0131n \u201c281-idame tedavi \u201ckoduyla&nbsp; i\u015fleme al\u0131nmas\u0131 gereklidir. \u0130dame tedavi i\u00e7in \u00e7\u0131kar\u0131lan raporun hatal\u0131 olarak 280- ba\u015flang\u0131\u00e7 tedavi koduyla sisteme y\u00fcklenmesi kesinti sebebidir ve 5.3.9 protokol h\u00fckm\u00fcne istinaden cezai i\u015flemle kar\u015f\u0131la\u015f\u0131lmamas\u0131 i\u00e7in uyar\u0131 kodlar\u0131na dikkat edilmesi gerekmektedir.&nbsp;<\/p>\n<p>***Gebelerde ba\u015flang\u0131\u00e7 ve devam rapor s\u00fcreleri toplamda 9 ay\u0131 ge\u00e7memelidir. G\u00fcncel gebelik haftas\u0131 rapor\/re\u00e7eteye eklenmelidir.&nbsp;<\/p>\n<p>***Gebe olan hastalarda uzam\u0131\u015f eski raporlar\u0131 i\u015fleme almamak gerekmektedir. Sut h\u00fck\u00fcmlerine uygun g\u00fcncel rapor aranmal\u0131d\u0131r.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bilindi\u011fi \u00fczere 25.08.2022 tarihli ve 31934 say\u0131l\u0131 resm\u00ee gazetede yay\u0131mlanan \u201cSosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde De\u011fi\u015fiklik Yap\u0131lmas\u0131na Dair Tebli\u011f \u201c kapsam\u0131nda Sa\u011fl\u0131k Uygulama Tebli\u011finin 4.2.7 D\u00fc\u015f\u00fck Molek\u00fcl A\u011f\u0131rl\u0131kl\u0131 Heparinlerin Kullan\u0131m ilkelerinde de de\u011fi\u015fikli\u011fe gidilmi\u015ftir. Buna istinaden Oksapar ,Enox vb. Enoksaparin i\u00e7eren m\u00fcstahzarlara ait \u00e7\u0131kar\u0131lacak ilk rapor uzman hekimlerce d\u00fczenlenen 3 ay s\u00fcreli sa\u011fl\u0131k raporudur. Bu ilk rapor 3 ay boyunca \u201c280-ba\u015flang\u0131\u00e7 tedavisi \u201cuyar\u0131 kodu ile i\u015fleme al\u0131nabilir.&nbsp; &nbsp;Daha sonra devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lmas\u0131 gereken raporlar en fazla 1 y\u0131l s\u00fcreli olup, rapor d\u00fczenlenme t\u00fcr\u00fc 3 hekimli SA\u011eLIK KURULU raporu olmal\u0131d\u0131r. Devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lan bu raporlar\u0131n \u201c281-idame tedavi \u201ckoduyla&nbsp; i\u015fleme al\u0131nmas\u0131 gereklidir. \u0130dame tedavi i\u00e7in \u00e7\u0131kar\u0131lan raporun hatal\u0131 olarak 280- ba\u015flang\u0131\u00e7 tedavi koduyla sisteme y\u00fcklenmesi kesinti sebebidir ve 5.3.9 protokol h\u00fckm\u00fcne istinaden cezai i\u015flemle kar\u015f\u0131la\u015f\u0131lmamas\u0131 i\u00e7in uyar\u0131 kodlar\u0131na dikkat edilmesi gerekmektedir.&nbsp; ***Gebelerde ba\u015flang\u0131\u00e7 ve devam rapor s\u00fcreleri toplamda 9 ay\u0131 ge\u00e7memelidir. G\u00fcncel gebelik haftas\u0131 rapor\/re\u00e7eteye eklenmelidir.&nbsp; ***Gebe olan hastalarda uzam\u0131\u015f eski raporlar\u0131 i\u015fleme almamak gerekmektedir. Sut h\u00fck\u00fcmlerine uygun g\u00fcncel rapor aranmal\u0131d\u0131r.<\/p>\n","protected":false},"author":4,"featured_media":191,"comment_status":"open","ping_status":"open","sticky":false,"template":"elementor_canvas","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5199","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oda"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"og:description\" content=\"Bilindi\u011fi \u00fczere 25.08.2022 tarihli ve 31934 say\u0131l\u0131 resm\u00ee gazetede yay\u0131mlanan \u201cSosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde De\u011fi\u015fiklik Yap\u0131lmas\u0131na Dair Tebli\u011f \u201c kapsam\u0131nda Sa\u011fl\u0131k Uygulama Tebli\u011finin 4.2.7 D\u00fc\u015f\u00fck Molek\u00fcl A\u011f\u0131rl\u0131kl\u0131 Heparinlerin Kullan\u0131m ilkelerinde de de\u011fi\u015fikli\u011fe gidilmi\u015ftir. Buna istinaden Oksapar ,Enox vb. Enoksaparin i\u00e7eren m\u00fcstahzarlara ait \u00e7\u0131kar\u0131lacak ilk rapor uzman hekimlerce d\u00fczenlenen 3 ay s\u00fcreli sa\u011fl\u0131k raporudur. Bu ilk rapor 3 ay boyunca \u201c280-ba\u015flang\u0131\u00e7 tedavisi \u201cuyar\u0131 kodu ile i\u015fleme al\u0131nabilir.&nbsp; &nbsp;Daha sonra devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lmas\u0131 gereken raporlar en fazla 1 y\u0131l s\u00fcreli olup, rapor d\u00fczenlenme t\u00fcr\u00fc 3 hekimli SA\u011eLIK KURULU raporu olmal\u0131d\u0131r. Devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lan bu raporlar\u0131n \u201c281-idame tedavi \u201ckoduyla&nbsp; i\u015fleme al\u0131nmas\u0131 gereklidir. \u0130dame tedavi i\u00e7in \u00e7\u0131kar\u0131lan raporun hatal\u0131 olarak 280- ba\u015flang\u0131\u00e7 tedavi koduyla sisteme y\u00fcklenmesi kesinti sebebidir ve 5.3.9 protokol h\u00fckm\u00fcne istinaden cezai i\u015flemle kar\u015f\u0131la\u015f\u0131lmamas\u0131 i\u00e7in uyar\u0131 kodlar\u0131na dikkat edilmesi gerekmektedir.&nbsp; ***Gebelerde ba\u015flang\u0131\u00e7 ve devam rapor s\u00fcreleri toplamda 9 ay\u0131 ge\u00e7memelidir. G\u00fcncel gebelik haftas\u0131 rapor\/re\u00e7eteye eklenmelidir.&nbsp; ***Gebe olan hastalarda uzam\u0131\u015f eski raporlar\u0131 i\u015fleme almamak gerekmektedir. Sut h\u00fck\u00fcmlerine uygun g\u00fcncel rapor aranmal\u0131d\u0131r.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/\" \/>\n<meta property=\"og:site_name\" content=\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-20T12:42:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-19T08:11:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Yeni Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Yeni Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tahmini okuma s\u00fcresi\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 dakika\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/\"},\"author\":{\"name\":\"Yeni Admin\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\"},\"headline\":\"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK.\",\"datePublished\":\"2023-01-20T12:42:00+00:00\",\"dateModified\":\"2026-01-19T08:11:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/\"},\"wordCount\":246,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"articleSection\":[\"ODA\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/\",\"name\":\"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"datePublished\":\"2023-01-20T12:42:00+00:00\",\"dateModified\":\"2026-01-19T08:11:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"contentUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/urfaeo-logo2.png\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/2023\\\/01\\\/20\\\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Anasayfa\",\"item\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#website\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#organization\",\"name\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"contentUrl\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/22022021211638-19929-73208.png\",\"width\":635,\"height\":635,\"caption\":\"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131\"},\"image\":{\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/#\\\/schema\\\/person\\\/f482a8288e46359eb9acced6151e1120\",\"name\":\"Yeni Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g\",\"caption\":\"Yeni Admin\"},\"url\":\"https:\\\/\\\/sanliurfaeo.birodam.org.tr\\\/index.php\\\/author\\\/yeniadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/","og_locale":"tr_TR","og_type":"article","og_title":"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","og_description":"Bilindi\u011fi \u00fczere 25.08.2022 tarihli ve 31934 say\u0131l\u0131 resm\u00ee gazetede yay\u0131mlanan \u201cSosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde De\u011fi\u015fiklik Yap\u0131lmas\u0131na Dair Tebli\u011f \u201c kapsam\u0131nda Sa\u011fl\u0131k Uygulama Tebli\u011finin 4.2.7 D\u00fc\u015f\u00fck Molek\u00fcl A\u011f\u0131rl\u0131kl\u0131 Heparinlerin Kullan\u0131m ilkelerinde de de\u011fi\u015fikli\u011fe gidilmi\u015ftir. Buna istinaden Oksapar ,Enox vb. Enoksaparin i\u00e7eren m\u00fcstahzarlara ait \u00e7\u0131kar\u0131lacak ilk rapor uzman hekimlerce d\u00fczenlenen 3 ay s\u00fcreli sa\u011fl\u0131k raporudur. Bu ilk rapor 3 ay boyunca \u201c280-ba\u015flang\u0131\u00e7 tedavisi \u201cuyar\u0131 kodu ile i\u015fleme al\u0131nabilir.&nbsp; &nbsp;Daha sonra devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lmas\u0131 gereken raporlar en fazla 1 y\u0131l s\u00fcreli olup, rapor d\u00fczenlenme t\u00fcr\u00fc 3 hekimli SA\u011eLIK KURULU raporu olmal\u0131d\u0131r. Devam tedavisi i\u00e7in \u00e7\u0131kar\u0131lan bu raporlar\u0131n \u201c281-idame tedavi \u201ckoduyla&nbsp; i\u015fleme al\u0131nmas\u0131 gereklidir. \u0130dame tedavi i\u00e7in \u00e7\u0131kar\u0131lan raporun hatal\u0131 olarak 280- ba\u015flang\u0131\u00e7 tedavi koduyla sisteme y\u00fcklenmesi kesinti sebebidir ve 5.3.9 protokol h\u00fckm\u00fcne istinaden cezai i\u015flemle kar\u015f\u0131la\u015f\u0131lmamas\u0131 i\u00e7in uyar\u0131 kodlar\u0131na dikkat edilmesi gerekmektedir.&nbsp; ***Gebelerde ba\u015flang\u0131\u00e7 ve devam rapor s\u00fcreleri toplamda 9 ay\u0131 ge\u00e7memelidir. G\u00fcncel gebelik haftas\u0131 rapor\/re\u00e7eteye eklenmelidir.&nbsp; ***Gebe olan hastalarda uzam\u0131\u015f eski raporlar\u0131 i\u015fleme almamak gerekmektedir. Sut h\u00fck\u00fcmlerine uygun g\u00fcncel rapor aranmal\u0131d\u0131r.","og_url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/","og_site_name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","article_published_time":"2023-01-20T12:42:00+00:00","article_modified_time":"2026-01-19T08:11:22+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","type":"image\/png"}],"author":"Yeni Admin","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Yeni Admin","Tahmini okuma s\u00fcresi":"1 dakika"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#article","isPartOf":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/"},"author":{"name":"Yeni Admin","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120"},"headline":"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK.","datePublished":"2023-01-20T12:42:00+00:00","dateModified":"2026-01-19T08:11:22+00:00","mainEntityOfPage":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/"},"wordCount":246,"commentCount":0,"publisher":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#primaryimage"},"thumbnailUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","articleSection":["ODA"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/","url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/","name":"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK. - \u015eanl\u0131urfa Eczac\u0131 Odas\u0131","isPartOf":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#primaryimage"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#primaryimage"},"thumbnailUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","datePublished":"2023-01-20T12:42:00+00:00","dateModified":"2026-01-19T08:11:22+00:00","breadcrumb":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#primaryimage","url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","contentUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/urfaeo-logo2.png","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/2023\/01\/20\/saglik-uygulama-tebliginin-4-2-7-dusuk-molekul-agirlikli-heparinlerin-kullanim-ilkeleri-hk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Anasayfa","item":"https:\/\/sanliurfaeo.birodam.org.tr\/"},{"@type":"ListItem","position":2,"name":"SA\u011eLIK UYGULAMA TEBL\u0130\u011e\u0130N\u0130N 4.2.7 D\u00dc\u015e\u00dcK MOLEK\u00dcL A\u011eIRLIKLI HEPAR\u0130NLER\u0130N KULLANIM \u0130LKELER\u0130 HK."}]},{"@type":"WebSite","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#website","url":"https:\/\/sanliurfaeo.birodam.org.tr\/","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","description":"","publisher":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sanliurfaeo.birodam.org.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Organization","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#organization","name":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131","url":"https:\/\/sanliurfaeo.birodam.org.tr\/","logo":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/logo\/image\/","url":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","contentUrl":"https:\/\/sanliurfaeo.birodam.org.tr\/wp-content\/uploads\/2025\/09\/22022021211638-19929-73208.png","width":635,"height":635,"caption":"\u015eanl\u0131urfa Eczac\u0131 Odas\u0131"},"image":{"@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/sanliurfaeo.birodam.org.tr\/#\/schema\/person\/f482a8288e46359eb9acced6151e1120","name":"Yeni Admin","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b1bcfc5d55af4e7fc9737f956325e8d9203056464179614b915004d0d1be29d3?s=96&d=mm&r=g","caption":"Yeni Admin"},"url":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/author\/yeniadmin\/"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts\/5199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/comments?post=5199"}],"version-history":[{"count":0,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/posts\/5199\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/media\/191"}],"wp:attachment":[{"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/media?parent=5199"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/categories?post=5199"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sanliurfaeo.birodam.org.tr\/index.php\/wp-json\/wp\/v2\/tags?post=5199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}